Logo-jcvtr

J Cardiovasc Thorac Res. 2020;12(2): 140-144. doi: 10.34172/jcvtr.2020.23
PMID: 32626555        PMCID: PMC7320999

Short Communication

Comparison of apolipoprotein-A1 levels between paroxysmal atrial fibrillation patients and healthy subjects

Tufan Çınar 1 * ORCID, Veysel Ozan Tanık 2, Kadir Gürkan 3

Cited by CrossRef: 5


1- Zhong X, Yu J, Zhao D, Teng J, Jiao H. Association between serum apolipoprotein A1 and atrial fibrillation in the Chinese population: a case–control study. BMC Cardiovasc Disord. 2023;23(1) [Crossref]
2- Štolbová K, Novodvorský P, Jakubíková I, Dvořáková I, Mráz M, Wichterle D, Kautzner J, Haluzík M. Effect of Complex Weight-Reducing Interventions on Rhythm Control in Obese Individuals with Atrial Fibrillation Following Catheter Ablation: A Study Protocol. Adv Ther. 2021;38(4):2007 [Crossref]
3- Li B, Ze F, Mi L, Chen X, Niu X, Hu S, Zhao N. Chief Editor Internatioal Journal of Cardiologyassessing Causality between Human Plasma Proteins and Atrial Fibrillation: A Two-Sample Mendelian Randomization Study. SSRN Journal. 2022; [Crossref]
4- Zhong X, Jiao H, Zhao D, Teng J. A case–control study to investigate association between serum uric acid levels and paroxysmal atrial fibrillation. Sci Rep. 2022;12(1) [Crossref]
5- Tajik B, Tuomainen T, Jarroch R, Kauhanen J, Lip G, Isanejad M. Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: A report from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD). Journal of Clinical Lipidology. 2022;16(4):447 [Crossref]